Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA CIPLA DISHMAN PHARMA/
CIPLA
 
P/E (TTM) x 30.0 32.2 93.0% View Chart
P/BV x 3.3 5.2 64.8% View Chart
Dividend Yield % 0.7 0.6 116.8%  

Financials

 DISHMAN PHARMA   CIPLA
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
CIPLA
Mar-23
DISHMAN PHARMA/
CIPLA
5-Yr Chart
Click to enlarge
High Rs3741,185 31.6%   
Low Rs129852 15.1%   
Sales per share (Unadj.) Rs197.0281.9 69.9%  
Earnings per share (Unadj.) Rs21.235.1 60.3%  
Cash flow per share (Unadj.) Rs34.749.7 69.9%  
Dividends per share (Unadj.) Rs2.008.50 23.5%  
Avg Dividend yield %0.80.8 95.2%  
Book value per share (Unadj.) Rs179.9289.2 62.2%  
Shares outstanding (eoy) m80.70807.15 10.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.33.6 35.4%   
Avg P/E ratio x11.929.0 41.0%  
P/CF ratio (eoy) x7.320.5 35.3%  
Price / Book Value ratio x1.43.5 39.7%  
Dividend payout %9.424.2 39.0%   
Avg Mkt Cap Rs m20,307822,164 2.5%   
No. of employees `000NANA-   
Total wages/salary Rs m5,35538,301 14.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,898227,531 7.0%  
Other income Rs m2655,121 5.2%   
Total revenues Rs m16,163232,653 6.9%   
Gross profit Rs m4,10348,079 8.5%  
Depreciation Rs m1,09111,721 9.3%   
Interest Rs m9441,095 86.2%   
Profit before tax Rs m2,33440,384 5.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m62412,029 5.2%   
Profit after tax Rs m1,71028,355 6.0%  
Gross profit margin %25.821.1 122.1%  
Effective tax rate %26.729.8 89.7%   
Net profit margin %10.812.5 86.3%  
BALANCE SHEET DATA
Current assets Rs m11,018168,051 6.6%   
Current liabilities Rs m9,51750,333 18.9%   
Net working cap to sales %9.451.7 18.2%  
Current ratio x1.23.3 34.7%  
Inventory Days Days5773 77.8%  
Debtors Days Days37 53.7%  
Net fixed assets Rs m18,787117,318 16.0%   
Share capital Rs m1611,614 10.0%   
"Free" reserves Rs m14,354231,845 6.2%   
Net worth Rs m14,516233,460 6.2%   
Long term debt Rs m4,1890-   
Total assets Rs m29,805290,067 10.3%  
Interest coverage x3.537.9 9.2%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.50.8 68.0%   
Return on assets %8.910.2 87.7%  
Return on equity %11.812.1 97.0%  
Return on capital %17.517.8 98.6%  
Exports to sales %24.922.6 109.9%   
Imports to sales %3.78.9 42.1%   
Exports (fob) Rs m3,95651,516 7.7%   
Imports (cif) Rs m59420,202 2.9%   
Fx inflow Rs m4,95264,282 7.7%   
Fx outflow Rs m69720,202 3.4%   
Net fx Rs m4,25544,080 9.7%   
CASH FLOW
From Operations Rs m2,78632,377 8.6%  
From Investments Rs m-1,529-23,885 6.4%  
From Financial Activity Rs m-941-9,583 9.8%  
Net Cashflow Rs m317-968 -32.7%  

Share Holding

Indian Promoters % 61.4 13.4 457.2%  
Foreign collaborators % 0.0 20.0 -  
Indian inst/Mut Fund % 23.0 50.0 45.9%  
FIIs % 12.0 25.7 46.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 66.5 58.0%  
Shareholders   52,291 425,731 12.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Dishman Pharma vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs Cipla Share Price Performance

Period Dishman Pharma Cipla S&P BSE HEALTHCARE
1-Day 2.87% 1.94% 1.18%
1-Month -2.45% 1.25% -0.75%
1-Year 96.38% 68.02% 61.82%
3-Year CAGR 89.34% 22.53% 18.16%
5-Year CAGR 38.20% 23.24% 19.79%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of Cipla the stake stands at 33.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

Cipla paid Rs 8.5, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.